Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$294K Sell
16,789
-43,215
-72% -$836K ﹤0.01% 3090
2026
Q1
$1.26M Buy
60,004
+46,195
+335% +$1.04M ﹤0.01% 1922
2025
Q4
$300K Buy
+13,809
New +$283K ﹤0.01% 2382
2024
Q3
Sell
-12,102
Closed -$297K 2967
2024
Q2
$297K Buy
+12,102
New +$292K ﹤0.01% 1506
2021
Q3
Sell
-20,346
Closed -$534K 3647
2021
Q2
$534K Buy
+20,346
New +$541K ﹤0.01% 1710
2021
Q1
Sell
-13,433
Closed -$374K 3047
2020
Q4
$374K Sell
13,433
-24,192
-64% -$673K 0.01% 1167
2020
Q3
$1.02M Buy
37,625
+10,951
+41% +$305K 0.03% 528
2020
Q2
$651K Buy
+26,674
New +$634K 0.02% 685

Other funds holding PHI

HRT Financial's PHI Position: Q2 2026 in Review

HRT Financial reduced its PLDT (PHI) stake by 72% in Q2 2026, selling an estimated $836K and leaving 16,789 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #3090.

HRT Financial first reported a position in PHI in Q2 2020 and has held it in 8 quarters since. The position peaked at $1.26M in Q1 2026. 100 funds tracked by Wall St. Rank hold PHI as of Q2 2026.

  • HRT Financial held 16,789 shares of PLDT worth $294K as of Q2 2026.
  • HRT Financial sold 43,215 PLDT shares in Q2 2026, an estimated $836K.
  • PLDT made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3090 holding.
  • HRT Financial first reported a position in PLDT in Q2 2020 and has held it in 8 quarters since.
  • HRT Financial's PLDT position peaked at $1.26M in Q1 2026.
  • 100 funds tracked by Wall St. Rank held PLDT as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.